Ozempic (semaglutide), like Trulicity, is a once-weekly and FDA-approved GLP-1 receptor agonist
Jeppesen DKAM, Fenix JL, Franklin, et al
While there is an incontrovertible acceptance of a relationship between obesity and cardiovascular disease (along with other medical conditions), there had been limited clinical evidence to support obesity drugs having the ability to materially address this issue prior to the release of the Select study
Overall, events are usually mild and reversible upon dose adjustment or discontinuation Pregnancy & Breastfeeding Animal reproduction studies have not demonstrated fetal harm with levocarnitine, and the drug is classified as Pregnancy Category B
It contains L-carnitine, an amino acid important for metabolism and the release of cellular energy
Studies have shown that overweight and obese adults who lose weight experience less pain and improved mobility